Candel Therapeutics (CADL) Non-Current Assets (2020 - 2025)

Candel Therapeutics' Non-Current Assets history runs 6 years deep, the most recent figure standing at $3.8 million for Q4 2025.

• In Q4 2025, Non-Current Assets rose 24.3% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $12.4 million (down 13.53% YoY), while the FY2025 annual figure was $3.8 million, up 24.3% from the prior year.
• Non-Current Assets came in at $3.8 million for Q4 2025 at Candel Therapeutics, up from $3.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $6.3 million in Q2 2021 to a low of $2.4 million in Q2 2025.
• A 5-year average of $4.5 million and a median of $4.4 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 35.84% in 2021 and tumbled 37.07% in 2025, its largest moves.
• Candel Therapeutics' Non-Current Assets stood at $4.3 million in 2021, then surged by 34.88% to $5.7 million in 2022, then fell by 23.36% to $4.4 million in 2023, then sank by 30.47% to $3.1 million in 2024, then advanced by 24.3% to $3.8 million in 2025.
• According to Business Quant data, Non-Current Assets over the past three periods registered $3.8 million, $3.5 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison